# Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

> **NCT03290534** · PHASE2 · RECRUITING · sponsor: **CivaTech Oncology** · enrollment: 40 (estimated)

## Conditions studied

- Lung Cancer
- Lung Cancer Stage I
- Lung Cancer Stage II

## Interventions

- **DEVICE:** CivaSheet

## Key facts

- **NCT ID:** NCT03290534
- **Lead sponsor:** CivaTech Oncology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-13
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03290534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03290534, "Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03290534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*